welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 488 blog entries.

October 2025 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (16/10/2025) confirmed the following initial list of price concessions for October 2025: Drug Pack size Price concession Amiodarone 100mg tablets 28 £2.74 Amiodarone 200mg tablets 28 £6.05 Co-careldopa 12.5mg/50mg tablets 90 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.38 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.80 Dutasteride [...]

The post October 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |October 16th, 2025|Lexpos News|Comments Off on October 2025 Price Concessions 1st Update

Medicine Supply Notification: Dalivit® Oral Drops

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Dalivit® Oral Drops MSN/2025/055 Tier 2 – medium impact Date of issue: 15/10/2025 Dalivit® Oral Drops are out of stock until further notice. Abidec® Multivitamin Drops remain available and can support increased demand. A copy of this [...]

The post Medicine Supply Notification: Dalivit® Oral Drops appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Dalivit® Oral Drops

Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]

The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]

The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

Retrospective price adjustment for Bisoprolol 5mg/5ml oral solution for August 2025

A licensed version of Bisoprolol 1mg/ml oral solution sugar free was launched by Aspire Pharma Ltd in August 2025. However, at the same time an unlicensed version of Bisoprolol 5mg/5ml oral solution was listed in Part VIIIB of the Drug Tariff. According to the Drug Tariff rules, any generically written prescription for Bisoprolol 5mg/5ml (or [...]

The post Retrospective price adjustment for Bisoprolol 5mg/5ml oral solution for August 2025 appeared first on Community Pharmacy England.

By |October 1st, 2025|Lexpos News|Comments Off on Retrospective price adjustment for Bisoprolol 5mg/5ml oral solution for August 2025